Cargando…
Advances in Pulmonary Drug Delivery
Pulmonary drug delivery represents an attractive, non-invasive administration option. In addition to locally acting drugs, molecules that are intended to produce systemic effects can be delivered via the pulmonary route. Several factors need to be considered in the context of delivering drugs to or...
Autores principales: | Yıldız-Peköz, Ayca, Ehrhardt, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598662/ https://www.ncbi.nlm.nih.gov/pubmed/32977672 http://dx.doi.org/10.3390/pharmaceutics12100911 |
Ejemplares similares
-
Lung Microbiota:
Its Relationship to Respiratory System
Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery
por: Yuksel, Nilufer, et al.
Publicado: (2023) -
Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations
por: Lam, Jenny K. W., et al.
Publicado: (2023) -
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
por: Sahin, Gokben, et al.
Publicado: (2022) -
Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects
por: Akbal-Dagistan, Ozlem, et al.
Publicado: (2022) -
Nanotechnology in Advanced Drug Delivery
por: Jain, Sanyog, et al.
Publicado: (2011)